NASDAQ:ABIO

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WIRE, ABIO, SWAV, MODN

Retrieved on: 
Monday, April 22, 2024
Sale, Vista Equity Partners, ARCA, Johnson & Johnson, Model N, Advertising, Shock wave, Fraud, Security (finance)

If you are an Encore shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are an Encore shareholder, click here to learn more about your rights and options .
  • If you are an ARCA shareholder, click here to learn more about your rights and options .
  • Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

Kuehn Law Encourages WIRE, ABIO, MODN, and SWAV Investors to Contact Law Firm

Retrieved on: 
Monday, April 22, 2024
Vista Equity Partners, ARCA, Johnson & Johnson, Advertising, PLLC, Model N, Human, Security (finance)

NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers.

Key Points: 
  • NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers.
  • Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.
  • According to the terms of the agreement, Encore Wire shareholders will be paid $290.00 per share.
  • Concerned shareholders are encouraged to contact Justin Kuehn, Esq., at [email protected] or call (833) 672-0814.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWAV, AIRC, ABIO, MODN

Retrieved on: 
Monday, April 15, 2024
Sale, Advertising, Johnson & Johnson, Model N, Shock wave, ARCA, Vista Equity Partners, Aimco, Fraud, Security (finance)

If you are a Shockwave shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Shockwave shareholder, click here to learn more about your rights and options .
  • If you are an Apartment Income shareholder, click here to learn more about your rights and options .
  • Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN), ARCA biopharma, Inc. (Nasdaq - ABIO)

Retrieved on: 
Monday, April 15, 2024
Model, Vista, AIR, JNJ, Johnson & Johnson, ARCA, Model N, Brodsky, Vista Equity Partners, Security (finance)

BALA CYNWYD, Pa., April 15, 2024 (GLOBE NEWSWIRE) --  Brodsky & Smith reminds investors of the following investigations.

Key Points: 
  • BALA CYNWYD, Pa., April 15, 2024 (GLOBE NEWSWIRE) --  Brodsky & Smith reminds investors of the following investigations.
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the Merger Agreement, Shockwave will be acquired by Johnson & Johnson (NYSE - JNJ).
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWAV, AIRC, MODN, ABIO

Retrieved on: 
Monday, April 8, 2024
ARCA, Model N, Shock wave, Sale, Aimco, Fraud, Johnson & Johnson, Vista Equity Partners, Advertising, Security (finance)

If you are a Shockwave shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Shockwave shareholder, click here to learn more about your rights and options .
  • If you are an Apartment Income shareholder, click here to learn more about your rights and options .
  • Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN), ARCA biopharma, Inc. (Nasdaq - ABIO)

Retrieved on: 
Monday, April 8, 2024
ARCA, Model N, JNJ, Brodsky, Johnson & Johnson, Vista Equity Partners, Model, AIR, Vista, Security (finance)

BALA CYNWYD, Pa., April 08, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.

Key Points: 
  • BALA CYNWYD, Pa., April 08, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the Merger Agreement, Shockwave will be acquired by Johnson & Johnson (NYSE - JNJ).
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWAV, KTRA, ABIO

Retrieved on: 
Friday, April 5, 2024
Advertising, Shock wave, ARCA, Sale, Therapy, Fraud, Johnson & Johnson, Security (finance)

If you are a Shockwave shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Shockwave shareholder, click here to learn more about your rights and options .
  • If you are a Kintara shareholder, click here to learn more about your rights and options .
  • Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

ARCA biopharma and Oruka Therapeutics Announce Merger Agreement

Retrieved on: 
Wednesday, April 3, 2024
Paragon, Freedom, Psoriasis, Biotechnology, ARCA, Disease, Patient, Paradigm, Psoriatic arthritis, Standard of care, Doctor of Philosophy, Investment, RTW, Engineering, Pharmaceutical industry

WESTMINSTER, Colo. and WALTHAM, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (NASDAQ: ABIO) (“ARCA”), and Oruka Therapeutics (“Oruka”), a privately held biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases, including plaque psoriasis, announced today that they have entered into a definitive agreement to combine the companies in an all-stock transaction. The resulting entity will focus on advancing Oruka’s pipeline of potentially best-in-class biologics, including ORKA-001 (an IL-23p19 inhibitor) and ORKA-002 (an IL-17A/F inhibitor). Upon completion of the merger, the combined company plans to operate under the name Oruka Therapeutics, Inc. and trade on Nasdaq under the ticker symbol “ORKA”.

Key Points: 
  • Upon completion of the merger, the combined company plans to operate under the name Oruka Therapeutics, Inc. and trade on Nasdaq under the ticker symbol “ORKA”.
  • In addition, prior to closing of the merger, ARCA expects to declare a cash dividend to the pre-merger ARCA stockholders equal to the amount by which ARCA’s net cash exceeds $5 million.
  • “Our mission at Oruka is to offer people affected with chronic skin diseases the most possible freedom from their condition.
  • Oruka is the third company founded based on assets generated by Paragon Therapeutics (“Paragon”).

ARCA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO

Retrieved on: 
Friday, April 5, 2024
Health, Professional Services, Class Action Lawsuit, Pharmaceutical, Legal, KSF, ARCA

and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of ARCA biopharma, Inc. (the “Company”) (NasdaqCM: ABIO) and Oruka Therapeutics.

Key Points: 
  • and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of ARCA biopharma, Inc. (the “Company”) (NasdaqCM: ABIO) and Oruka Therapeutics.
  • Upon closing of the proposed transaction, ARCA shareholders are expected to own approximately 2.38% of the combined company.
  • KSF is seeking to determine whether the merger and the process that led to it are adequate, and whether the merger is fair to ARCA shareholders.
  • To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .

ABIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ARCA Biopharma, Inc. Is Fair to Shareholders

Retrieved on: 
Wednesday, April 3, 2024
Legal, Professional Services, Advertising, Fraud, ARCA

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of ARCA biopharma, Inc. (NASDAQ: ABIO) and Oruka Therapeutics is fair to ARCA shareholders.

Key Points: 
  • Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of ARCA biopharma, Inc. (NASDAQ: ABIO) and Oruka Therapeutics is fair to ARCA shareholders.
  • Upon closing of the proposed transaction, ARCA shareholders are expected to own approximately 2.38% of the combined company.
  • On behalf of ARCA shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.